People · Operator
Named in public records as an officer, director or promoter · active 2023–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mach5 Therapeutics, Inc. | — | Biotechnology | Series B | $23.4M | $119.5M | 2024 |
| AlmataBio, Inc. | — | Biotechnology | Seed | $2.1M | $14.5M | 2023 |
| AstralBio, Inc. | — | Biotechnology | Pre-Seed | $957K | $3.4M | 2024 |
Justin J. DiMartino at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Justin J. DiMartino on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick J. Crutcher | 3 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.